Illumina, Inc.

NasdaqGS:ILMN 주식 보고서

시가총액: US$16.8b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Illumina 과거 수익 실적

과거 기준 확인 0/6

Illumina의 수입은 연평균 -60%의 비율로 감소해 온 반면, Life Sciences 산업은 수입이 연평균 16.8%의 비율로 증가했습니다. 매출은 연평균 7.7%의 비율로 증가해 왔습니다.

주요 정보

-60.0%

수익 성장률

-59.8%

EPS 성장률

Life Sciences 산업 성장21.5%
매출 성장률7.7%
자기자본 수익률-22.5%
순이익-28.7%
다음 실적 업데이트06 Aug 2024

최근 과거 실적 업데이트

Recent updates

Illumina, Inc.'s (NASDAQ:ILMN) Share Price Could Signal Some Risk

Jul 01
Illumina, Inc.'s (NASDAQ:ILMN) Share Price Could Signal Some Risk

Illumina: Marriage Made In Hell Is (Finally) Over - Assessing Impact Of GRAIL Spin-Out

Jun 28

Should You Investigate Illumina, Inc. (NASDAQ:ILMN) At US$106?

May 26
Should You Investigate Illumina, Inc. (NASDAQ:ILMN) At US$106?

Illumina: Expect A Slow Rebound

May 07

Calculating The Fair Value Of Illumina, Inc. (NASDAQ:ILMN)

Apr 26
Calculating The Fair Value Of Illumina, Inc. (NASDAQ:ILMN)

Revenues Not Telling The Story For Illumina, Inc. (NASDAQ:ILMN)

Mar 20
Revenues Not Telling The Story For Illumina, Inc. (NASDAQ:ILMN)

Illumina: Stagnant Revenues And Shrinking Margins Amidst Rising Competition

Feb 23

Would Illumina (NASDAQ:ILMN) Be Better Off With Less Debt?

Jan 26
Would Illumina (NASDAQ:ILMN) Be Better Off With Less Debt?

Illumina: Volatility Galore, But Not Much Prospect Of Progress In 2024

Jan 19

Investors Appear Satisfied With Illumina, Inc.'s (NASDAQ:ILMN) Prospects As Shares Rocket 40%

Dec 21
Investors Appear Satisfied With Illumina, Inc.'s (NASDAQ:ILMN) Prospects As Shares Rocket 40%

Is Illumina, Inc. (NASDAQ:ILMN) Potentially Undervalued?

Dec 03
Is Illumina, Inc. (NASDAQ:ILMN) Potentially Undervalued?

Would Illumina (NASDAQ:ILMN) Be Better Off With Less Debt?

Oct 24
Would Illumina (NASDAQ:ILMN) Be Better Off With Less Debt?

Is There An Opportunity With Illumina, Inc.'s (NASDAQ:ILMN) 40% Undervaluation?

Oct 03
Is There An Opportunity With Illumina, Inc.'s (NASDAQ:ILMN) 40% Undervaluation?

At US$167, Is Illumina, Inc. (NASDAQ:ILMN) Worth Looking At Closely?

Aug 22
At US$167, Is Illumina, Inc. (NASDAQ:ILMN) Worth Looking At Closely?

The Big Trends: New Frontiers in Healthcare

Jul 13
The Big Trends: New Frontiers in Healthcare

Estimating The Intrinsic Value Of Illumina, Inc. (NASDAQ:ILMN)

Jul 03
Estimating The Intrinsic Value Of Illumina, Inc. (NASDAQ:ILMN)

Illumina (NASDAQ:ILMN) Is Carrying A Fair Bit Of Debt

Jun 13
Illumina (NASDAQ:ILMN) Is Carrying A Fair Bit Of Debt

Is It Time To Consider Buying Illumina, Inc. (NASDAQ:ILMN)?

Apr 12
Is It Time To Consider Buying Illumina, Inc. (NASDAQ:ILMN)?

Is Illumina (NASDAQ:ILMN) Using Too Much Debt?

Mar 14
Is Illumina (NASDAQ:ILMN) Using Too Much Debt?

Are Investors Undervaluing Illumina, Inc. (NASDAQ:ILMN) By 38%?

Dec 30
Are Investors Undervaluing Illumina, Inc. (NASDAQ:ILMN) By 38%?

Should You Investigate Illumina, Inc. (NASDAQ:ILMN) At US$221?

Dec 02
Should You Investigate Illumina, Inc. (NASDAQ:ILMN) At US$221?

These 4 Measures Indicate That Illumina (NASDAQ:ILMN) Is Using Debt Reasonably Well

Oct 27
These 4 Measures Indicate That Illumina (NASDAQ:ILMN) Is Using Debt Reasonably Well

Illumina, GenoScreen collaborate on genomic testing for drug-resistant TB

Oct 18

Illumina in research collaboration with AstraZeneca on drug target discovery

Oct 11

Illumina Engages Obama To Push Its Customers' Reimbursement Agenda

Sep 29

수익 및 비용 분석

Illumina 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.

수익 및 매출 내역

NasdaqGS:ILMN 수익, 비용 및 수입 (USD Millions )
날짜수익수익G+A 비용R&D 비용
31 Mar 244,493-1,2901,6461,204
31 Dec 234,504-1,1611,6371,207
01 Oct 234,465-1,1251,6101,248
02 Jul 234,461-4,1861,6361,272
02 Apr 234,448-4,4871,6361,227
01 Jan 234,584-4,4041,6141,209
02 Oct 224,700-4,1531,6821,242
03 Jul 224,693-201,5101,187
03 Apr 224,6567011,5501,061
02 Jan 224,5267621,744914
03 Oct 214,2809071,351794
04 Jul 213,9667691,350696
04 Apr 213,4736301,114650
03 Jan 213,2396561,014609
27 Sep 203,238638813572
28 Jun 203,351693811551
29 Mar 203,556942835562
29 Dec 193,5431,002907575
29 Sep 193,458973874607
30 Jun 193,405938881615
31 Mar 193,397851877600
30 Dec 183,333826849568
30 Sep 183,243684798538
01 Jul 183,103648768513
01 Apr 182,936567732492
31 Dec 172,752725720500
01 Oct 172,594775692488
02 Jul 172,487741664480
02 Apr 172,424730652474
01 Jan 172,398454630458
02 Oct 162,371440624450
03 Jul 162,314430621423
03 Apr 162,253415597395
03 Jan 162,220462561362
27 Sep 152,141510533348
28 Jun 152,071486516334
29 Mar 151,979430506321
28 Dec 141,861353499306
28 Sep 141,736281478294
29 Jun 141,612219453279
30 Mar 141,511208430264
29 Dec 131,421125423249
29 Sep 131,343117378212

양질의 수익: ILMN 은(는) 현재 수익성이 없습니다.

이익 마진 증가: ILMN 은(는) 현재 수익성이 없습니다.

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

수익추이: ILMN 은(는) 수익성이 없으며 지난 5년 동안 연간 60% 비율로 손실이 증가했습니다.

성장 가속화: 현재 수익성이 없기 때문에 ILMN 의 지난 1년 동안의 수익 성장을 5년 평균과 비교할 수 없습니다.

수익 대 산업: ILMN 은(는) 수익성이 없어 지난 해 수익 성장을 Life Sciences 업계( -6.5% )와 비교하기 어렵습니다.

자기자본 수익률

높은 ROE: ILMN 현재 수익성이 없기 때문에 마이너스 자본 수익률( -22.5% )을 갖습니다.

자산 수익률

고용 자본 수익률

과거 성과가 우수한 기업 찾기

7D

1Y

7D

1Y

7D

1Y